Hashimoto Koshi, Yamada Masanobu, Matsumoto Shunichi, Monden Tsuyoshi, Satoh Teturou, Mori Masatomo
Department of Medicine and Molecular Science, Graduate School of Medicine, Gunma University, 3-39-15 Showa-machi Maebashi, Gunma 371-8511, Japan.
Endocrinology. 2006 Sep;147(9):4292-302. doi: 10.1210/en.2006-0116. Epub 2006 Jun 22.
Sterol regulatory element-binding protein (SREBP)-1c is a key regulator of fatty acid metabolism and plays a pivotal role in the transcriptional regulation of different lipogenic genes mediating lipid synthesis. In previous studies, the regulation of SREBP-1c mRNA levels by thyroid hormone has remained controversial. In this study, we examined whether T3 regulates the mouse SREBP-1c mRNA expression. We found that T3 negatively regulates the mouse SREBP-1c gene expression in the liver, as shown by ribonuclease protection assays and real-time quantitative RT-PCR. Promoter analysis with luciferase assays using HepG2 and Hepa1-6 cells revealed that T3 negatively regulates the mouse SREBP-1c gene promoter (-574 to +42) and that Site2 (GCCTGACAGGTGAAATCGGC) located around the transcriptional start site is responsible for the negative regulation by T3. Gel shift assays showed that retinoid X receptor-alpha/thyroid hormone receptor-beta heterodimer bound to Site2, but retinoid X receptor-alpha/liver X receptor- heterodimer could not bind to the site. In vivo chromatin immunoprecipitation assays demonstrated that T3 induced thyroid hormone receptor-beta recruitment to Site2. Thus, we demonstrated that mouse SREBP-1c mRNA is down-regulated by T3 in vivo and that T3 negatively regulates mouse SREBP-1c gene transcription via a novel negative thyroid hormone response element: Site2.
固醇调节元件结合蛋白(SREBP)-1c是脂肪酸代谢的关键调节因子,在介导脂质合成的不同生脂基因的转录调控中起关键作用。在先前的研究中,甲状腺激素对SREBP-1c mRNA水平的调节一直存在争议。在本研究中,我们检测了T3是否调节小鼠SREBP-1c mRNA的表达。我们发现,核糖核酸酶保护试验和实时定量RT-PCR结果表明,T3对小鼠肝脏中SREBP-1c基因表达具有负调控作用。利用HepG2和Hepa1-6细胞进行的荧光素酶报告基因检测的启动子分析显示,T3对小鼠SREBP-1c基因启动子(-574至+42)具有负调控作用,转录起始位点附近的位点2(GCCTGACAGGTGAAATCGGC)负责T3的负调控。凝胶迁移试验表明,视黄酸X受体-α/甲状腺激素受体-β异二聚体与位点2结合,但视黄酸X受体-α/肝脏X受体-异二聚体不能与该位点结合。体内染色质免疫沉淀试验表明,T3诱导甲状腺激素受体-β募集到位点2。因此,我们证明了小鼠SREBP-1c mRNA在体内被T3下调,并且T3通过一个新的负性甲状腺激素反应元件:位点2对小鼠SREBP-1c基因转录进行负调控。